DE3887014D1 - Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen. - Google Patents

Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen.

Info

Publication number
DE3887014D1
DE3887014D1 DE88109952T DE3887014T DE3887014D1 DE 3887014 D1 DE3887014 D1 DE 3887014D1 DE 88109952 T DE88109952 T DE 88109952T DE 3887014 T DE3887014 T DE 3887014T DE 3887014 D1 DE3887014 D1 DE 3887014D1
Authority
DE
Germany
Prior art keywords
nucleosides
preparation
pharmaceutical compositions
infections
dideoxynucleosides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88109952T
Other languages
English (en)
Other versions
DE3887014T2 (de
Inventor
Samuel Broder
Hiroaki Mitsuya
Steve Tam
Manfred Weigele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
US Department of Health and Human Services
Original Assignee
F Hoffmann La Roche AG
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG, US Department of Health and Human Services filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE3887014D1 publication Critical patent/DE3887014D1/de
Publication of DE3887014T2 publication Critical patent/DE3887014T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
DE3887014T 1987-06-22 1988-06-22 Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen. Expired - Fee Related DE3887014T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/064,631 US4837311A (en) 1987-06-22 1987-06-22 Anti-retroviral compounds

Publications (2)

Publication Number Publication Date
DE3887014D1 true DE3887014D1 (de) 1994-02-24
DE3887014T2 DE3887014T2 (de) 1994-05-19

Family

ID=22057259

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3887014T Expired - Fee Related DE3887014T2 (de) 1987-06-22 1988-06-22 Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen.

Country Status (6)

Country Link
US (1) US4837311A (de)
EP (1) EP0296573B1 (de)
JP (1) JPH02262587A (de)
AT (1) ATE100098T1 (de)
DE (1) DE3887014T2 (de)
DK (1) DK336688A (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187163A (en) * 1987-03-27 1993-02-16 Baker Norton Pharmaceuticals, Inc. Anti-viral compounds, dosage forms and methods
ZA886890B (en) * 1987-10-09 1989-05-30 Hoffmann La Roche Novel dideoxycytidine derivatives
FR2631964B1 (fr) * 1988-05-31 1990-09-07 Pasteur Institut Glucosyl phosphotriesters de derives de thymidine ayant une activite contre les retrovirus
US5216141A (en) * 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
US5849482A (en) * 1988-09-28 1998-12-15 Epoch Pharmaceuticals, Inc. Crosslinking oligonucleotides
US5824796A (en) * 1988-09-28 1998-10-20 Epoch Pharmaceuticals, Inc. Cross-linking oligonucleotides
USRE38416E1 (en) 1988-09-28 2004-02-03 Epoch Biosciences, Inc. Cross-linking oligonucleotides
NZ232912A (en) * 1989-03-17 1992-06-25 Oncogen Ltd Lp Synergistic composition of nucleoside derivatives for inhibiting hiv
US5585364A (en) * 1989-04-13 1996-12-17 British Technology Group Limited Antiviral compounds
EP0472648A4 (en) * 1989-05-18 1992-09-16 Microprobe Corporation Crosslinking oligonucleotides
AU7759291A (en) * 1990-03-29 1991-10-21 Gilead Sciences, Inc. Oligonucleotide-transport agent disulfide conjugates
US5430138A (en) * 1990-07-27 1995-07-04 Chiron Corporation Hydroxyl-protecting groups attached to cytidine nucleotide compounds which are orthogonally removable
US5561225A (en) * 1990-09-19 1996-10-01 Southern Research Institute Polynucleotide analogs containing sulfonate and sulfonamide internucleoside linkages
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
JPH06510020A (ja) * 1991-03-29 1994-11-10 ユニバーシティ・オブ・フロリダ 混成リン酸エステル誘導体を経た標的への薬剤供給
DE550714T1 (de) * 1991-06-21 1995-06-14 Acic Canada Inc Antiviralverbindungen und Ihrer Verfahren zur Herstellung.
US6136601A (en) * 1991-08-21 2000-10-24 Epoch Pharmaceuticals, Inc. Targeted mutagenesis in living cells using modified oligonucleotides
US5693791A (en) * 1995-04-11 1997-12-02 Truett; William L. Antibiotics and process for preparation
EP0970065A4 (de) * 1997-11-29 2001-03-07 William L Truett Antibiotika und verfahren zu ihrer herstellung
CN100522967C (zh) 2002-02-01 2009-08-05 阿里亚德基因治疗公司 含磷化合物及其应用
IL149298A0 (en) * 2002-04-23 2002-11-10 Lycored Natural Prod Ind Ltd Tomato product and method for obtaining same
AU2003300901A1 (en) * 2002-12-12 2004-06-30 Idenix (Cayman) Limited Process for the production of 2'-branched nucleosides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
EP0199451B1 (de) * 1985-03-16 1996-03-06 The Wellcome Foundation Limited Therapeutische Nukleoside
CA1314875C (en) * 1985-05-15 1993-03-23 George Walter Koszalka Therapeutic nucleosides
GB2181128A (en) * 1985-09-17 1987-04-15 Wellcome Found 3'-azidonucleosides
CA1330794C (en) * 1987-03-27 1994-07-19 Phillip Frost Anti-viral compounds, dosage forms and methods

Also Published As

Publication number Publication date
JPH02262587A (ja) 1990-10-25
DK336688D0 (da) 1988-06-20
EP0296573A2 (de) 1988-12-28
EP0296573B1 (de) 1994-01-12
DE3887014T2 (de) 1994-05-19
DK336688A (da) 1988-12-23
ATE100098T1 (de) 1994-01-15
US4837311A (en) 1989-06-06
EP0296573A3 (en) 1990-07-04

Similar Documents

Publication Publication Date Title
DE3887014D1 (de) Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen.
DK224286D0 (da) 2',3'-dideoxy-nucleosider
DE69015509T2 (de) Aluminiumoxidkeramik, ihre herstellung und wegwerfstück daraus.
ATE185483T1 (de) Antivirale nucleosidkombination
DE3877406D1 (de) Benzothiazolinon-derivate, ihre herstellung und pharmazeutische zusammensetzung.
FI892454A0 (fi) Nya bensimidazolderivat, foerfarande foer framstaellning av desamma och farmaceutisk komposition innehaollande desamma.
DE3887273D1 (de) 2',3'-Dideoxy-2'-fluornucleoside.
NL960024I2 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus besmette patiënten.
DE3782828T2 (de) Interleukin-2-zusammensetzungen.
ATE71840T1 (de) Virushemmende nukleosidmischung.
EP0311108A3 (de) Anti-HIV-aktive 3'-Azido-2,6-diaminopurine-2',3'-dideoxyriboside
FI933165A (fi) Nya fosfolipidderivat
DE3767175D1 (de) Therapeutische zusammenstellungen auf basis von 3-alkoxyflavonen und derivate von 3-alkoxyflavonen.
MX9203274A (es) Benzazepinas condensadas, composiciones de las mismas y uso medicinal de estas.
DE59107240D1 (de) Emulgatorfreie Emulsionspolymere in pharmazeutischen Zubereitungen mit verzögerter Wirkstofffreigabe und ihre Herstellung
ES2066897T3 (es) 5,11-dihidro-6h-pirido(2,3-b)(1,4)benzodiazepin-6-onas y -tionas y su uso en la prevencion o el tratamiento del sida.
ES2043896T3 (es) Procedimiento para la preparacion de derivados de tetrahidropiridina.
DE3773128D1 (de) Cyclopentanaether, ihre herstellung und pharmazeutische formulierung.
DE3764233D1 (de) Cyclopentylaether, deren herstellung und pharmazeutische formulierung.
IT8622051A0 (it) Composizioni farmaceutiche adattivita' cicatrizzante.
ATE104966T1 (de) 9-(acylamino)tetrahydroacridinderivate und wahrnehmungssteigernde mittel davon als aktiver wirkstoff.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee